Design of a Drug-Eluting Subcutaneous Implant of the Antiretroviral Tenofovir Alafenamide Fumarate

PURPOSE: Sexual transmission of HIV has been clinically proven to be preventable with a once-daily oral tablet; however, missed doses dramatically increase the risk of HIV infection. Long-acting subcutaneous implants do not allow the user to miss a dose. A desirable long-acting drug-eluting implant...

Descripción completa

Detalles Bibliográficos
Autores principales: Simpson, Solange M, Widanapathirana, Lakmini, Su, Jonathan T., Sung, Samuel, Watrous, David, Qiu, Jiang, Pearson, Elizabeth, Evanoff, Alex, Karunakaran, Dipu, Chacon, Jorge E., Kiser, Patrick F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160069/
https://www.ncbi.nlm.nih.gov/pubmed/32296951
http://dx.doi.org/10.1007/s11095-020-2777-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160069/
https://www.ncbi.nlm.nih.gov/pubmed/32296951
http://dx.doi.org/10.1007/s11095-020-2777-2

Ejemplares similares